pCPA Activity Overview
Status | Total Negotiations | Summary |
---|---|---|
Active Negotiations | 32 | Non-oncology: 20 Oncology: 12 |
Under Consideration for Negotiation | 23 | Non-oncology: 17 Oncology: 6 |
Completed Negotiations | 416 | With Letter of Intent: 359 Without agreement: 57 |
Negotiations That Were Not Pursued | 81 |
pCPA Activity in the last four weeks
Activity for the last four weeks. Please note that these updates may take one to two weeks to be processed.
Engagement Letters Issued in the last four weeks
Brand Name | Manufacturer | Indication | Engagement Date |
---|---|---|---|
Soliris | Alexion Pharma GMBH | Myasthenia Gravis | |
Tecentriq and bevacizumab | HOFFMANN-LA ROCHE LIMITED | Hepatocellular Carcinoma (HCC) |